Hyperammonaemia
Gene: HLCS
Holocarboxylase synthetase deficiency, a biotin-responsive multiple carboxylase deficiency (MCD), is characterised by metabolic acidosis, lethargy, hypotonia, convulsions, and dermatitis. Most individuals present in the newborn or early infantile period, but some become symptomatic in the later infantile period. Well established gene-disease association.Created: 1 Sep 2020, 4:52 a.m. | Last Modified: 1 Sep 2020, 4:52 a.m.
Panel Version: 0.4073
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Holocarboxylase synthetase deficiency, MIM# 253270
Loss of function - transfected fibroblasts show reduced enzyme activity (PMID: 10190325)Created: 1 Sep 2020, 2:49 a.m. | Last Modified: 1 Sep 2020, 2:49 a.m.
Panel Version: 0.4059
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Holocarboxylase synthetase deficiency, 253270
Publications
Tag treatable tag was added to gene: HLCS.
gene: HLCS was added gene: HLCS was added to Hyperammonaemia. Sources: Genomics England PanelApp,Expert Review Green Mode of inheritance for gene: HLCS was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: HLCS were set to Holocarboxylase synthetase deficiency 253270